SRPT logo

SRPT
Sarepta Therapeutics Inc

26,717
Mkt Cap
$2.33B
Volume
3.88M
52W High
$129.84
52W Low
$10.42
PE Ratio
-7.68
SRPT Fundamentals
Price
$21.60
Prev Close
$22.20
Open
$21.16
50D MA
$20.93
Beta
1.08
Avg. Volume
6.23M
EPS (Annual)
$2.34
P/B
1.76
Rev/Employee
$1.39M
Loading...
Loading...
News
all
press releases
Why Is SRPT Stock Falling Today?
Sarepta Therapeutics announced a debt refinancing plan totaling about $291 million.
Stocktwits·5h ago
News Placeholder
More News
News Placeholder
Sarepta Therapeutics Announces Refinancing of Approximately $291 Million of 1.25% Convertible Senior Notes due 2027
Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today announced that it has entered into separate, privately negotiated exchange agreements with...
Business Wire·9h ago
News Placeholder
Sarepta Therapeutics, Inc. $SRPT Shares Bought by Federated Hermes Inc.
Federated Hermes Inc. grew its holdings in shares of Sarepta Therapeutics, Inc. (NASDAQ:SRPT - Free Report) by 347.8% during the second quarter, according to its most recent Form 13F filing with the...
MarketBeat·1d ago
News Placeholder
Sarepta Therapeutics (NASDAQ:SRPT) Shares Gap Up - What's Next?
Sarepta Therapeutics (NASDAQ:SRPT) Shares Gap Up - What's Next...
MarketBeat·2d ago
News Placeholder
Sarepta Therapeutics (NASDAQ:SRPT) Coverage Initiated by Analysts at Wedbush
Wedbush began coverage on Sarepta Therapeutics in a research report on Tuesday. They issued an "outperform" rating and a $32.00 price target for the company...
MarketBeat·2d ago
News Placeholder
New York State Common Retirement Fund Sells 7,923,000 Shares of Sarepta Therapeutics, Inc. $SRPT
New York State Common Retirement Fund cut its stake in Sarepta Therapeutics, Inc. (NASDAQ:SRPT - Free Report) by 98.4% in the 2nd quarter, according to the company in its most recent disclosure with...
MarketBeat·2d ago
News Placeholder
New York State Common Retirement Fund Sells 7,923,000 Shares of Sarepta Therapeutics, Inc. $SRPT
New York State Common Retirement Fund cut its stake in Sarepta Therapeutics, Inc. (NASDAQ:SRPT - Free Report) by 98.4% in the 2nd quarter, according to the company in its most recent disclosure with...
MarketBeat·2d ago
News Placeholder
Norges Bank Buys Shares of 913,407 Sarepta Therapeutics, Inc. $SRPT
Norges Bank purchased a new position in shares of Sarepta Therapeutics, Inc. (NASDAQ:SRPT - Free Report) in the 2nd quarter, according to the company in its most recent 13F filing with the Securities...
MarketBeat·2d ago
News Placeholder
Norges Bank Buys Shares of 913,407 Sarepta Therapeutics, Inc. $SRPT
Norges Bank purchased a new position in shares of Sarepta Therapeutics, Inc. (NASDAQ:SRPT - Free Report) in the 2nd quarter, according to the company in its most recent 13F filing with the Securities...
MarketBeat·2d ago
News Placeholder
Sarepta Therapeutics (NASDAQ:SRPT) Shares Gap Down - Time to Sell?
Sarepta Therapeutics (NASDAQ:SRPT) Shares Gap Down - Here's Why...
MarketBeat·7d ago

Latest SRPT News

View

Advertisement|Remove ads.

Advertisement|Remove ads.